These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18375496)

  • 1. Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9.
    Jung K; Klotzek S; Stephan C; Mannello F; Lein M
    Clin Chem; 2008 Apr; 54(4):772-3. PubMed ID: 18375496
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.
    Thrailkill KM; Moreau CS; Cockrell G; Simpson P; Goel R; North P; Fowlkes JL; Bunn RC
    Clin Chem Lab Med; 2005; 43(12):1392-9. PubMed ID: 16309379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blood collection methods on gelatin zymography of matrix metalloproteinases.
    Mannello F
    Clin Chem; 2003 Feb; 49(2):339-40. PubMed ID: 12560371
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome.
    Michizono K; Umehara F; Hashiguchi T; Arimura K; Matsuura E; Watanabe O; Fujimoto N; Okada Y; Osame M
    Neurology; 2001 Mar; 56(6):807-10. PubMed ID: 11274326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia.
    Lorenzl S; De Pasquale G; Segal AZ; Beal MF
    Stroke; 2003 Jun; 34(6):e37-8; author reply e37-8. PubMed ID: 12750528
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Profile of Circulating Matrix Metalloproteinases in Patients Undergoing Lower Limb Endovascular Interventions for Peripheral Arterial Disease.
    Giagtzidis IT; Kadoglou NP; Mantas G; Spathis A; Papazoglou KO; Karakitsos P; Liapis CD; Karkos CD
    Ann Vasc Surg; 2017 Aug; 43():188-196. PubMed ID: 28288884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer.
    Kuropkat C; Plehn S; Herz U; Dünne AA; Renz H; Werner JA
    Anticancer Res; 2002; 22(4):2221-7. PubMed ID: 12174907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of High Intensity Interval Training on Matrix Metalloproteinases in Women with Breast Cancer Receiving Anthracycline-Based Chemotherapy.
    Lee K; Kang I; Mack WJ; Mortimer J; Sattler F; Salem G; Dieli-Conwright CM
    Sci Rep; 2020 Apr; 10(1):5839. PubMed ID: 32246106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case-control study in the Multiethnic Cohort study.
    Kim Y; Ollberding NJ; Shvetsov YB; Franke AA; Wilkens LR; Maskarinec G; Hernandez BY; Le Marchand L; Henderson BE; Kolonel LN; Goodman MT
    Breast Cancer Res Treat; 2012 Dec; 136(3):837-45. PubMed ID: 23112106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease.
    Friese RS; Rao F; Khandrika S; Thomas B; Ziegler MG; Schmid-Schönbein GW; O'Connor DT
    Clin Exp Hypertens; 2009 Oct; 31(7):521-33. PubMed ID: 19886850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation.
    Abdallah MA; Nakajima ST; Lin PC; Gercel-Taylor C
    Fertil Steril; 2005 Dec; 84(6):1766-7. PubMed ID: 16359987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample processing and its preanalytical impact on the measurement of circulating matrix metalloproteinases.
    Jung K
    Clin Chem Lab Med; 2006; 44(4):500-2. PubMed ID: 16599848
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating levels of matrix metalloproteinases in heart transplant recipients.
    Dorent R; Beaudeux JL; Tezenas S; Ghossoub JJ; Roussouliere AL; Leger P; Vaissier E; Bonnet N; Leprince P; Regan M; Pavie A; Foglietti MJ; Cacoub P; Gandjbakhch I
    Transplant Proc; 2000 Dec; 32(8):2750-1. PubMed ID: 11134786
    [No Abstract]   [Full Text] [Related]  

  • 16. Matrix metalloproteinases 2, 7, and 9 and tissue inhibitor of metalloproteinases-1 in tumors and serum of patients with ovarian neoplasms.
    Gershtein ES; Levkina NV; Digayeva MA; Laktionov KP; Tereshkina IV; Kushlinsky NE
    Bull Exp Biol Med; 2010 Oct; 149(5):628-31. PubMed ID: 21165404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia.
    Karapanagiotidis GT; Antonitsis P; Charokopos N; Foroulis CN; Anastasiadis K; Rouska E; Argiriadou H; Rammos K; Papakonstantinou C
    J Cardiothorac Surg; 2009 Nov; 4():59. PubMed ID: 19886986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases during and outside of migraine attacks without aura.
    Ashina M; Tvedskov JF; Lipka K; Bilello J; Penkowa M; Olesen J
    Cephalalgia; 2010 Mar; 30(3):303-10. PubMed ID: 19614693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Matrix metalloproteinase-1, -2 and -3].
    Nakamura H
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():514-6. PubMed ID: 15628461
    [No Abstract]   [Full Text] [Related]  

  • 20. [Age-related dynamics of the contents of matrix metalloproteinases (MMP-1, -2, -3, -9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -4) in blood plasma of residents of the European part of the Arctic zone of the Russian Federation.].
    Kim LB; Russkih GS; Putyatina AN; Tsypysheva OB
    Adv Gerontol; 2018; 31(2):223-230. PubMed ID: 30080329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.